ABIRATONE ACETATE 250MG

Abiratone Acetate 250mg Tablets are a prescription hormonal therapy used in the treatment of metastatic castration-resistant prostate cancer (mCRPC) and metastatic hormone-sensitive prostate cancer (mHSPC). This targeted therapy is designed to help manage advanced prostate cancer by controlling hormone levels that drive tumor growth.

Abiraterone works by inhibiting the CYP17 enzyme, which is essential for androgen production. Lowering testosterone levels helps slow cancer progression, reduce tumor stimulation, and support better disease control. This therapy is typically prescribed alongside corticosteroids to enhance effectiveness and manage side effects.

Taken strictly under oncologist supervision, Abiraterone Acetate 250 mg Tablets provide targeted, long-term hormonal management for advanced prostate cancer. Its oral tablet form ensures convenient daily administration while delivering clinically proven prostate cancer therapy as part of a comprehensive treatment plan.

Product Features

• Androgen biosynthesis inhibitor (CYP17 inhibitor)
• Used in advanced prostate cancer treatment
• Reduces testosterone production from all sources
• Oral tablet for convenient administration
• Typically used with prednisone or prednisolone
• Prescription-only oncology medication

How It Helps

• Blocks the CYP17 enzyme to reduce androgen production, lowering testosterone levels
• Slows the growth and progression of metastatic prostate cancer
• Supports the management of castration-resistant and hormone-sensitive prostate cancer
• Used with corticosteroids to enhance effectiveness and maintain hormonal balance